American National Insurance Co. TX held its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) during the second quarter, Holdings Channel reports. The institutional investor owned 65,650 shares of the medical research company’s stock at the end of the second quarter. American National Insurance Co. TX’s holdings in Thermo Fisher Scientific were worth $11,454,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in TMO. Independent Portfolio Consultants Inc. raised its stake in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock valued at $112,000 after buying an additional 2 shares during the last quarter. Sharkey Howes & Javer raised its stake in shares of Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after buying an additional 7 shares during the last quarter. Washington Trust Bank raised its stake in shares of Thermo Fisher Scientific by 0.5% in the first quarter. Washington Trust Bank now owns 2,210 shares of the medical research company’s stock valued at $339,000 after buying an additional 10 shares during the last quarter. Beacon Trust Co. raised its stake in shares of Thermo Fisher Scientific by 0.6% in the first quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock valued at $341,000 after buying an additional 12 shares during the last quarter. Finally, Dumont & Blake Investment Advisors LLC raised its stake in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Dumont & Blake Investment Advisors LLC now owns 5,526 shares of the medical research company’s stock valued at $849,000 after buying an additional 15 shares during the last quarter. 86.93% of the stock is currently owned by institutional investors.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded down 0.09% during trading on Monday, reaching $180.79. The company’s stock had a trading volume of 1,294,256 shares. The firm’s 50-day moving average is $173.88 and its 200 day moving average is $158.53. The company has a market cap of $70.73 billion, a PE ratio of 32.98 and a beta of 1.06. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $182.40.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, April 26th. The medical research company reported $2.08 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.02 by $0.06. The firm had revenue of $4.77 billion for the quarter, compared to the consensus estimate of $4.68 billion. Thermo Fisher Scientific had a return on equity of 15.73% and a net margin of 11.58%. The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.80 EPS. On average, equities research analysts predict that Thermo Fisher Scientific Inc will post $9.23 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.95%.

WARNING: “Thermo Fisher Scientific Inc (NYSE:TMO) Stake Maintained by American National Insurance Co. TX” was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/07/17/thermo-fisher-scientific-inc-nysetmo-stake-maintained-by-american-national-insurance-co-tx.html.

Several analysts have recently weighed in on the company. Jefferies Group LLC lifted their price objective on Thermo Fisher Scientific from $160.00 to $175.00 and gave the stock a “hold” rating in a report on Friday, April 28th. Deutsche Bank AG set a $200.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Saturday, June 10th. Wells Fargo & Company reissued an “outperform” rating and set a $200.00 price objective (up previously from $195.00) on shares of Thermo Fisher Scientific in a report on Thursday. Bank of America Corporation lifted their price objective on Thermo Fisher Scientific from $190.00 to $200.00 and gave the stock a “buy” rating in a report on Tuesday, May 9th. Finally, BTIG Research lifted their price objective on Thermo Fisher Scientific from $180.00 to $190.00 and gave the stock a “buy” rating in a report on Friday, April 28th. Two investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $186.71.

In other Thermo Fisher Scientific news, insider Thomas W. Loewald sold 1,532 shares of the firm’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $168.76, for a total value of $258,540.32. Following the sale, the insider now owns 41,277 shares of the company’s stock, valued at approximately $6,965,906.52. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Marc N. Casper sold 20,000 shares of the firm’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $172.79, for a total value of $3,455,800.00. Following the completion of the sale, the chief executive officer now directly owns 269,279 shares in the company, valued at approximately $46,528,718.41. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,720 shares of company stock worth $4,960,764. Company insiders own 0.49% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.